Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × balstilimab × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Recruiting 3 Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 98 pembrolizumab 83 Gemcitabine 80 fludarabine 61 Carboplatin 60 Nivolumab 56 Cisplatin 53 Radiotherapy 50 Paclitaxel 50 Docetaxel 49 Rituximab 46 Dexamethasone 41 Lenalidomide 40 Ipilimumab 37 Azacitidine 36 Etoposide 33 Cytarabine 33 Temozolomide 32 Bevacizumab 30 venetoclax 29 Radiation 29 Bortezomib 27 Magnetic Resonance Spectroscopy 26 Irinotecan 26 atezolizumab 24 Pemetrexed 24 Capecitabine 24 Oxaliplatin 23 fludarabine phosphate 22 Filgrastim 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04156100 2022-03-03

A Study in Subjects With Advanced Solid Tumors

Agenus Inc.

Phase 1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡